Versant Venture Management, LLC Adverum Biotechnologies, Inc. Transaction History
Versant Venture Management, LLC
- $45 Million
- Q2 2024
A detailed history of Versant Venture Management, LLC transactions in Adverum Biotechnologies, Inc. stock. As of the latest transaction made, Versant Venture Management, LLC holds 506,821 shares of ADVM stock, worth $3.76 Million. This represents 7.72% of its overall portfolio holdings.
Number of Shares
506,821
Previous 506,822
-0.0%
Holding current value
$3.76 Million
Previous $7.17 Million
51.49%
% of portfolio
7.72%
Previous 9.99%
Shares
6 transactions
Others Institutions Holding ADVM
# of Institutions
4Shares Held
2.53MCall Options Held
0Put Options Held
0About Adverum Biotechnologies, Inc.
- Ticker ADVM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 99,333,600
- Market Cap $736M
- Description
- Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...